mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?

Bibliographic Details
Main Authors: David J. Kwiatkowski, Nikhil Wagle, MD
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396414000632
_version_ 1818467806150131712
author David J. Kwiatkowski
Nikhil Wagle, MD
author_facet David J. Kwiatkowski
Nikhil Wagle, MD
author_sort David J. Kwiatkowski
collection DOAJ
first_indexed 2024-04-13T21:05:00Z
format Article
id doaj.art-d28d0ebca2504b759539ee4380d894b6
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-13T21:05:00Z
publishDate 2015-01-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-d28d0ebca2504b759539ee4380d894b62022-12-22T02:30:00ZengElsevierEBioMedicine2352-39642015-01-01212410.1016/j.ebiom.2014.12.011mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?David J. Kwiatkowski0Nikhil Wagle, MD1Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United StatesDepartment of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United Stateshttp://www.sciencedirect.com/science/article/pii/S2352396414000632
spellingShingle David J. Kwiatkowski
Nikhil Wagle, MD
mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
EBioMedicine
title mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
title_full mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
title_fullStr mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
title_full_unstemmed mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
title_short mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
title_sort mtor inhibitors in cancer what can we learn from exceptional responses
url http://www.sciencedirect.com/science/article/pii/S2352396414000632
work_keys_str_mv AT davidjkwiatkowski mtorinhibitorsincancerwhatcanwelearnfromexceptionalresponses
AT nikhilwaglemd mtorinhibitorsincancerwhatcanwelearnfromexceptionalresponses